Circadian Dysregulation Clinical Trial
Official title:
Maintaining Behavior Change: An Evaluation of a Habit-based Sleep Health Intervention
NCT number | NCT05167695 |
Other study ID # | 2021-06-14409 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 4, 2022 |
Est. completion date | July 1, 2026 |
The study will test a sleep-health intervention that leverages the science on habit formation. It will evaluate if adding a text messaging intervention improves habit formation. The participants will be 18-30 years old.
Status | Recruiting |
Enrollment | 160 |
Est. completion date | July 1, 2026 |
Est. primary completion date | December 20, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 30 Years |
Eligibility | Inclusion Criteria: 1. Scoring less than or equal to 26 on the Composite Scale of Morningness OR Mid-point of sleep later than 4:30 AM for 18-24 yo and 3:50 AM for 25-30 yo on work-free/weekend days over the past month OR Night-to-night variation in sleep and wake times across one month of 2 hours or more. 2. 'At risk' in one of the five health domains: the emotional domain, the cognitive domain, the behavioral domain, the physical domain and the social domain. "Risk" is defined as scoring 4 or higher on one item from an adapted version of the Work and Social Adjustment Scale. 3. Age between 18 and 30. 4. English language fluency. 5. Able and willing to give informed assent. 6. If taking medication for sleep, the dose and frequency of use must have been stable for at least 4 weeks. Exclusion Criteria: 1. Presence of substance abuse/dependence, mental illness, physical illness, suicidality or developmental disorder only if it makes participation in the study unfeasible or if there is a significant risk of harm and/or decompensation if treatment of that comorbid condition is delayed due to participating in this study. 2. Evidence of sleep apnea, restless legs or periodic limb movements during sleep. Youth presenting with provisional diagnoses of any of these disorders will be referred for a non-study polysomnography evaluation and will be enrolled only if the diagnosis is disconfirmed or if the disorder is treated. 3. Night shifter worker where the shift is scheduled between the hours of midnight to 6am > 2 nights per week. 4. Pregnancy or breast-feeding. |
Country | Name | City | State |
---|---|---|---|
United States | University of California | Berkeley | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Berkeley |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Adapted version of the Work and Social Adjustment Scale (individual items) | A measure of emotional, cognitive, physical, social and behavioral risk. The 5 items are each rated on a 0-8 scale. The 5 individual item scores will be reported separately (range: 0 to 8; Higher score means worse outcome). | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | Self Report Habit Index: Secondary habit bundle to build | 1 item rated on 1-5 scale. Scores can range from 1 to 5 | At the end of the 2nd through last treatment session, which starts 2 to 3 weeks after the beginning of treatment. Also at 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | Self Report Habit Index: Secondary habit bundle to dismantle | 1 items rated on 1-5 scale. Scores can range from 1 to 5 | At the end of the 2nd through last treatment session, which starts 2 to 3 weeks after the beginning of treatment. Also at 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | Height | (cm) | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | Weight | Pounds (lbs) | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | Hip circumference | (cm) | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | Waist circumference | (cm) | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | Sleep Diary | (Not a scale); Consensus sleep diary variables, including total sleep time, bedtime, and wake-time, calculated separately for weekdays and weekends. | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | Actigraphy | (Not a scale); Sleep parameters, including sleep onset time, sleep offset time, and total sleep time, calculated separately for weekdays and weekends. | Change from baseline to 1-week post treatment | |
Other | Sussex-Oxford Compassion Scale (SOCS) | Sum of 20-item, 5-point response scale. Scores can range from 20 to 100 (Higher score means higher compassion for self).
Sub-scale items included. |
Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | Suicidal Behavior Questionnaire - Revised | 4-item. Total scores can range from 3-18 (Higher Score means higher Suicidal ideation)
Sub-scale items included. |
Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | Alexian Brothers Urge to Self Injure Scale | 5-item. 0-6 point scale. Total scores can range from 0-30 (Higher Score means higher Suicidal ideation) | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | State authenticity | A measure of state authenticity. The 4 items are each rated on a 1-7 scale. The sum is averaged (range 1-7; higher scores mean more authenticity) | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Other | Past month estimates of sleep mid-point workfree days and night-to-night sleep variability | Questions to assess mid-point and night-to-night variability eligibility criteria | Once at baseline | |
Other | Sleep Medication Log | Questions to assess use of medications | Once at baseline | |
Other | Credibility Expectancy Questionnaire | first 3 items are on a 1-9 scale. The final item is on a 0-100 scale. (Higher score means the treatment was evaluated as more credible). | After the 2nd treatment session, which is 2 to 3 weeks after the beginning of treatment. Again at the post-treatment assessment which is 1-week post treatment | |
Other | Adverse Events Checklist | 16 items to assess adverse events experienced during treatment | At the 1-week post treatment assessment only | |
Other | Proportion of text messages read | 1 item rated from 0% to 100% | At the 1-week post treatment assessment only | |
Other | Script Elicitation Worksheet | (Not a scale); Individualized for each patient, the worksheet includes primary and secondary habit bundles to build and dismantle (e.g., sleep-onset habits, WASO habits, rise-up habits, daytime habits, sleep efficiency habits), and strategy to dismantle primary and secondary habit bundles (e.g., substitution, removing or curtailing, reorganizing) | After starting treatment, at the end of the 1st through 3rd treatment session (week 1 through week 3 of treatment) | |
Primary | Self-Report Automaticity Habits Index integrated with the Utilization Scale | 16-item; 0-4 scale. Scores can range from 0 to 64 (Higher score means more automaticity in utilization). | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Primary | Utilization Scale | 16-item; 0-4 scale. Scores can range from 0 to 64 (Higher score means more utilization). | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Primary | Composite Sleep Health Score | Composite Sleep Health Score which is defined as the sum of scores on 6 sleep health dimensions: Regularity (Midpoint fluctuation), Satisfaction (Sleep quality question on PROMIS-SD), Alertness (Daytime sleepiness question on PROMIS-SRI), Timing (Mean midpoint), Efficiency (Sleep efficiency) and Duration (Total Sleep Time). The Sleep Health Composite was constructed such that higher score indicates better sleep health. | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Primary | Composite Scale of Morningness | Sum of 13-item; Mix of 4-point and 5-point response scale. Scores can range from 13 (extreme evening) to 55 (extreme morning). | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Primary | Patient-Reported Outcomes Measurement Information System - Sleep Related Impairment (PROMIS-SRI) | Sum of 8-items rated on a 5-point response scale. Scores can range from 8 to 40 (Higher score means more Sleep Related impairment) | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Primary | Patient-Reported Outcomes Measurement Information System - Sleep Disturbance (PROMIS-SD) | Sum of 8-items rated on a 5-point response scale. Scores can range from 8 to 40 (Higher score means more Sleep Disturbance) | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Primary | Adapted version of the Work and Social Adjustment Scale | A measure of emotional, cognitive, physical, social and behavioral risk. The 5 items are each rated on a 0-8 scale. The 5 individual item scores will be summed into a total score (range: 0 to 40; Higher score means worse outcome). | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Secondary | Pittsburgh Sleep Quality Index | 19-item. First four items are integer responses. The rest of the items are on a 0-3 scale. Creates 7 composite scores, with the sum of the composite scores ranging from 0 to 21. (Higher score means increased severity of difficulty in all sleep area components). | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Secondary | Sleep Diary | (Not a scale); Night-to-night variability in the mid-point of sleep | Baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Secondary | Actigraphy | (Not a scale); Night-to-night variability in the mid-point of sleep | Baseline to 1-week post treatment | |
Secondary | Depression, Anxiety, and Stress Scale (DASS) | Three subscales-depression, anxiety, stress-of 7 items each, ranging from 0-3 per item. Subscale scores range from 0-21. Final scores are multiplied by two. Higher scores mean worse outcomes. Total score will also be calculated. | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Secondary | Brief Sensation Seeking Scale | 8-item; 5-point response scale; Scores can range from 8 to 40 (Higher score means higher sensation seeking). | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Secondary | Physical Health Questionnaire | Sum of 15-item, 0-2 response scale. Scores can range from 0 to 30 (Higher score means worse physical symptoms) | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Secondary | PROMIS-Cognitive Function | 6-item; 1-5 response scale. Scores can range from 6-30 (Higher score means better cognitive functioning) | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Secondary | PROMIS-Ability to participate | 4-item; 1-5 response scale. Scores can range from 4-20 (Higher score means better social functioning) | Change from baseline to 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Secondary | Ecological Momentary Assessment Composite Risk Score of Functioning - Emotion | (Not a scale) Measured via Ecological Momentary Assessment. a 16-item version of the Positive and Negative Affect Schedule will be administered. The Positivity Ratio will also be calculated. | Change from baseline to 1-week post treatment | |
Secondary | Ecological Momentary Assessment Composite Risk Score of Functioning - Cognitive Domain | (Not a scale) Measured via Ecological Momentary Assessment. Concentration, distractedness and focus are rated on a 5 point scale. | Change from baseline to 1-week post treatment | |
Secondary | Ecological Momentary Assessment (EMA) Composite Risk Score of Functioning - Behavioral Domain | (Not a scale) Measured via Ecological Momentary Assessment. The investigators assess eating, caffeine, alcohol, nicotine, marijuana, opioids and prescription and over the counter (OTC) stimulants and sleep aids. Participants will also be asked to list the use of additional psychoactive drugs (e.g. cocaine). The investigators tabulate the average weekly frequency and intake of each substance. | Change from baseline to 1-week post treatment | |
Secondary | Ecological Momentary Assessment Composite Risk Score of Functioning - Social Domain | (Not a scale) Measured via Ecological Momentary Assessment. will assess if the participant is with anyone at the time of the call. Positivity Ratio (see EMA for Emotional Health) will be calculated when the participant is alone, with a family member or with a friend. | Change from baseline to 1-week post treatment | |
Secondary | Ecological Momentary Assessment Composite Risk Score of Functioning - Physical Domain | (Not a scale) Measured via Ecological Momentary Assessment. Physical activity and sedentary behaviors will be assessed. | Change from baseline to 1-week post treatment | |
Secondary | Self Report Habit Index: Primary habit bundle to build | 6 items rated on 1-5 scale. Scores can range from 1 to 30 | At the end of the 2nd through last treatment session, which starts 2 to 3 weeks after the beginning of treatment. Also at 1-week post treatment, 6-month follow-up and 12-month follow-up | |
Secondary | Self Report Habit Index: Primary habit bundle to dismantle | 6 items rated on 1-5 scale. Scores can range from 0 to 30 | At the end of the 2nd through last treatment session, which starts 2 to 3 weeks after the beginning of treatment. Also at 1-week post treatment, 6-month follow-up and 12-month follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03188263 -
Morning Light Treatment to Improve Glucose Metabolism
|
N/A | |
Recruiting |
NCT05995132 -
Compromised Sleep and Circadian Health After Critical Illness: From Diagnosis to Prediction (CHRONOCRIT)
|
||
Completed |
NCT05070143 -
Mini-treatment Experiments to Clarify How to Assist People to Habit Formation
|
N/A | |
Recruiting |
NCT03747367 -
The Microbiome and Resilience to Sleep and Circadian Disruption
|
N/A | |
Recruiting |
NCT02954809 -
Effects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT04364646 -
Personalized Integrated Chronotherapy for Perinatal Depression
|
N/A | |
Withdrawn |
NCT00907595 -
Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
|
N/A | |
Completed |
NCT04373538 -
Improving Well-being by Improving Memory for Treatment for Sleep and Circadian Dysfunction
|
N/A | |
Active, not recruiting |
NCT03388788 -
Body Weight, Sleep, and Heart Health
|
Early Phase 1 | |
Completed |
NCT03934177 -
Impact of Blueberry Consumption on Gastrointestinal Health
|
N/A | |
Completed |
NCT02291952 -
Development of Countermeasures Against Adverse Metabolic Effects of Shift Work
|
N/A | |
Completed |
NCT05263232 -
Metabolic Effects of Natural Office Light in Type 2 Diabetes
|
N/A | |
Recruiting |
NCT02674230 -
OCEAN Registry: Obesity and Clock for Elegant Aging Registry
|
||
Recruiting |
NCT04021355 -
Timing of Sodium Intake and Nocturnal Sodium Excretion and Blood Pressure in Obese African Americans
|
N/A | |
Completed |
NCT03636360 -
The Impact of Artificial Sunlight on Human Sleep and Circadian Rhythms
|
N/A | |
Recruiting |
NCT04154631 -
Implementing and Sustaining a Sleep Treatment to Improve Community Mental Part 1: Implementation Health Outcomes
|
N/A | |
Recruiting |
NCT05986604 -
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
|
N/A | |
Completed |
NCT04111900 -
Effect of Sleep on the Recovery of Patients Admitted to the ICU
|
N/A | |
Completed |
NCT00492011 -
Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers
|
Phase 4 | |
Completed |
NCT03680989 -
A Pilot Test of Mood and Circadian Rhythm Mechanisms Driving Binge Eating
|
N/A |